TABLE 1.
Demographics and baseline characteristicsa
| Characteristic | Tai Chi intervention group (N = 27) |
|---|---|
| Demographics | |
| Age, mean (SD), years | 41.1 (16.2) |
| Female | 25 (92.6) |
| BMI, mean (SD), kg/m2 | 23.5 (3.6) |
| Race | |
| American Indian/Alaska Native | 0 (0) |
| Asian | 4 (14.8) |
| Native Hawaiian/Pacific Islander | 3 (11.1) |
| Black/African Americana | 1 (3.7) |
| White | 22 (81.5) |
| More than one race | 0 (0) |
| Hispanic/Latinx | 2 (7.4) |
| Psychological comorbidities | |
| HADS anxiety, mean (SD) | 9.7 (3.7) |
| HADS depression, mean (SD) | 5.4 (3.4) |
| HADS total, mean (SD) | 15.1 (6.2) |
| Concomitant medications | |
| Laxatives | 23 (85.2) |
| Miralax | 6 (22.2) |
| Dulcolax | 6 (22.2) |
| Sennosides | 2 (7.4) |
| Enema | 3 (11.1) |
| Linaclotide | 3 (11.1) |
| Magnesium | 3 (11.1) |
| Neuromodulators | 9 (33.3) |
| SSRIs | 5 (18.5) |
| SNRIs | 1 (3.7) |
| Tricyclic antidepressant | 2 (7.4) |
| Gabapentin | 1 (3.7) |
| Seen GI provider for symptoms | 10 (37.0) |
| Referral source | |
| MGH GI clinic | 12 (44.4) |
| Recruitment website | 12 (44.4) |
| Facebook ad | 1 (3.7) |
| Word of mouth | 2 (7.4) |
Abbreviations: SD, standard deviation; BMI, body mass index; HADS, hospital anxiety and depression score; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin-norepinephrine reuptake inhibitor; MGH, Massachusetts General Hospital
a
Data are shown as number (percentage) unless otherwise noted. Percentages are rounded.